Human melanoma cell invasion: selected neurotrophin enhancement of invasion and hep aranase activity

Journal of Investigative Dermatology Symposium Proceedings

Volumn 2, Issue 1, 1997, Pages 99-105

  Marchetti, Dario ^a,b   Nicolson, Garth L ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b T'Nstitute for Molecular Medicine   (United States)

Author keywords

Glycans processing; Metastatic mclanotnalinvasionlheparan sulfatelproteoelycanslglycosamino ; Nerve growth factorlbrain

Indexed keywords

HEPARANASE; NEUROTROPHIN;

CANCER INVASION; CELL PROLIFERATION; CONFERENCE PAPER; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MELANOMA; METASTASIS POTENTIAL;

BIOCOMPATIBLE MATERIALS; BRAIN NEOPLASMS; COLLAGEN; DRUG COMBINATIONS; GLUCURONIDASE; GLYCOSIDE HYDROLASES; HUMANS; LAMININ; MELANOMA; NEOPLASM INVASIVENESS; NERVE GROWTH FACTORS; OLIGONUCLEOTIDES, ANTISENSE; PROTEOGLYCANS; RECEPTORS, NERVE GROWTH FACTOR; TUMOR CELLS, CULTURED;

EID: 0030879578     PISSN: 10870024     EISSN: None     Source Type: Journal    
DOI: 10.1038/jidsymp.1997.19     Document Type: Article

References (43)

1. Barbacid M: Nerve growth factor: a tale of two receptors. Oncogenc 8:2033-2044, 1993
2. Bothwell M: Tissue localization of nerve growth factor and nerve growth factor receptors. Curr Top Microbiol Immimol 165:55-70, 1991
3. Chao MV: Growth factor signaling: where is the specificity? Cell 68:995-997, 1992
4. Cohen IR, Murdoch AD, Naso MF, Marchetd D, Berd D, lozzo RV: Abnormal expression of perlecan in metastatic melanoma, Cancer R 54:5771-5774, 1994
5. Dietrich CP, Sampio LO, Toledo OM: Characteristic distribution of sulfatcd mucoporysaccharides in different tissues and in their respective mitochondria. Biochctn Biophvs Res Commun 71:1-10, 1976
6. Escandon E. Burton LE, Szonyi E, Nikolics K: Characterization of neurotrophin receptors by affinity crosslinking. J Neurosci Res 34:601-613, 1993
7. Fabricant RN, De Larco JE, Todaro GL: Nerve growth factor receptors on human melanoma cells in culture. Proc Nad Acad SciVSA 74:565-569, 1977
8. Hedman K, Kurkinen M, Alitalo K, Vaheri A, Johansson S, Hook M: Isolation of the pericellular matrix of human fibroblast cultures. J Cell Bid 81:83-91, 1979
9. Hefti F: Neurotrophic factor therapy for nervous system degenerative diseases. J Keumbiol 25:1418-1435, 1994
10. Herlyn M, Human melanoma: development and progression. Cancer Metastasis Rev 9:101-112, 1990
11. Herrmann JH, Menter DG, Hamada J, Marchetti D, Nakajima M, Nicolson GL: Mediation of NGF-stimulated extracellular matrix invasion by die human melanoma low-affinity p75 neurotrophin receptor: melanoma p75 functions independently of trkA. AW Biol Cell 4:1205-1216, 1993
12. Ibanez CF, Efbendal T, Barbany G, Murray-Rust J, Blundell TL, Persson H: Disruption of the low affinity receptor-binding site in NGF allows neuronal survival and differentiation by binding to the trk gene product. Cell 69:329-341, 1992
13. Iozzo RV: Proteoglycans: structure, function and role in neoplasia. Lab Invest 53:373-396, 1985
14. Iozzo RV, Cohen IR, Grassei S, Murdoch AD: The biology of perlecan: the multifaceted heparan sulfate proteoglycan of basement membranes and pericellular matrices. Biochem J 302:625-639, 1994
15. Iozzo RV, Murdoch AD: Proteoglycans of the extracellular environment: clues from the gene and protein side offer novel perspectives in molecular diversity and function.R4SEBJ 10:598-614, 1996
16. Ishikawa M, Femandez B, Kerbel RS: Highly pigmented human melanoma variant which metastasizes widely in nude mice, including to skin and brain. Cancer Res 48:4897-4903, 1988
17. Jin L, Nakajima M, Nicolson GL: Immunochemical localization of heparanase in mouse and human melanomas. IntJ Cancer 45:1088-1095, 1990
18. Johnson D, Lanahan A, Buck CR, Sehgal A, Morgan C, Mercer E, Bothwell M, Chao M: Expression and structure of the human NGF receptor. Cell 4:545-554, 1986
19. Kaplan DR, Hempstead BL, Martin ZD, Chao MV, Parada LF: The Irk protooncogene product: a signal transducing receptor for nerve growth factor. Science 252:554-558, 1991
20. Lamballe F, Klein R, Barbacid M: TrkC, a new member of the TRK family of tyrosine protein kinase, is a receptor for neurotrophin-3. Cell 66:967-979, 1991
21. Marchetti D, McCutcheon I, Ross MJ, Nicolson GL: Inverse expression of neurotrophin receptor and neurotrophins at the invasion front of brain-metastatic human melanoma tissues. IntJ Oncol 7:87-94, 1995
22. Marchetti D, McManaman JL: Characterization of nerve growth factor binding to embryonic rat spinal cord neurons. J Natrosci Res 27:211-218, 1990
23. Marchetti D, McQuillan D, Spohn WC, Carson DD, Nicolson GL: Neurotrophin stimulation of human melanoma cell invasion: selected NT enhancement of heparanase activity and heparanase degradation of specific heparan sulfate subpopulations. Cancer Ru 56:2856-2863, 1996
24. Marchetti D, Menter D, Jin L, Nakajima M, Nicolson GL: Nerve growth factor effects on human and mouse melanoma cell invasion and heparanase production. Int J Cancer 55:692-699, 1993
25. Marchetti D, Nicolson GL: Selected neurotrophins enhancement of heparanase activity and heparanase degradation of specific heparan sulfate subpopulations. Adv Enzyme Reg, in press, 1997
26. Menter DG, Herrmann JL, Marchetti D, Nicolson GL: Involvement of neurotrophins and growth factors in brain metastasis formation. Invasion Metastasis 14:372-384, 1995
27. Menter DG, Hermann JL, Nicolson GL: The role of trophic factors and autocrine/ paracrine growth factors in brain metastasis. Clin Exp Metastasis 13:67-88, 1995
28. Moscatelli D, Rifkin B: Membrane and matrix localization of proteinases: a common theme in tumor cell invasion and angiogenesis. Bitxhim Biophys ArtJ 948:67-85, 1988
29. Murdoch AD, Liu B, Schwarting R, Tuan RS, lozzo RV: Widespread expression of perlecan proteoglycan in basement membranes and extracellular matrices of human tissues as detected by a novel monoclonal antibody against domain III and by in situ hybridization. J Histxhetn Cytxhem 42:239-249, 1994
30. Nakajima M, Irimura T, Di Ferrante D, Di Ferrante N, Nicolson GL: Heparan sulfate degradation: relation to tumor invasive and metastatic properties of mouse B16 melanoma sublines. Science 220:611-613, 1983
31. Nakajima M, Irimura T, Di Ferrante N, Nicolson GL: Metastatic melanoma heparanase. JBM Chem 259:2283-2290, 1984
32. NakajimaM, Irimura T, Nicolson GL: A solid phase substrate of heparanase: its application to assay of human melanoma for heparan sulfate degradative activity. AnalDmhem 157:162-171, 1986
33. Nakajima M, Irimura T, Nicolson GL: Heparanase and tumor metastasis. J Cell Bhchem 36:157-167, 1986
34. Nicolson GL: Metastatic tumor cell interactions with endothelium, basement membrane and tissue. CHIT Opin Cell Bid 1:1009-1019, 1989
35. Nicolson GL, Menter DG, Herrmann JL, Cavanaugh P, Jia L, Hamada J, Yun Z, Marchetti D: Tumor metastasis to brain: role of endothelial cells, neurotrophin, and paracrinc growth factors. Crit Reif Oncog 5:451-471, 1994
36. Nicolson GL, Nakajima M, Hemnann JL, Monter DG, Cavanaugh P, Park JS, Marchetti D: Malignant melanoma metastasis to brain: role of degradative enzymes and responses to paracrine growth factors. J Neurooticol 18:139-149, 1994
37. Patel JK, Didolkar MS, Pickren JW, Moore RH: Metastatic pattern of malignant melanoma. A study of 216 autopsy cases. Am J Surg 135:807-810, 1978
38. Rohde LH, Carson DD: Heparin-like glycosaminoglycans participate in binding of a human trophoblastic cell Une (JAR) to a human uterine epithelial cell line (RL95). J Cell Pliysiot 155:185-196, 1993
39. Sariola H, Saarma M, Sainio K, Arumaae U, Palgi J, Vaahtokari A, Thesleff I, Karavanov A: Dependence of kidney morphogenesis on the expression of nerve growth factor receptor. Seime 254:571-573, 1991
40. Thoenen H, Bandtlow C, Heuman R: The physiological function of nerve growth factor in the central nervous system: comparison with the periphery. Rev Physiot Blocken: Pharmacol 109:145-178, 1987
41. Tryggvason K, Hoyhtya M, Salo T: Proteolytic degradation of extracellular matrix in tumor invasion. Biochim Diophys Acta 907:191-217, 1987
42. Way DL, Grosso PS, Davis JR, Sum-it EA, Christian CD: Characterization of a new human endometrial carcinoma (RL95-2) established in tissue culture. In Vitro 19:147-158, 1983
43. Whittemore SC, Seiger A: The expression, localization and functional significance of β-nerve growth factor in the central nervous system. Neitrosci Rev 12:439-464, 1987